[Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
date : 5/1/2023
![[Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/amr-20230316-top_ENG.png)
On March 16, 2023, Health and Global Policy Institute (HGPI) submitted opinions (public comments) regarding “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)”. (The call for public comments is now closed.)
An outline of the submitted opinions is provided below. For further details, please refer to the PDF file.
Summary
Since Japan’s National Action Plan on Antimicrobial Resistance (AMR) came into effect in 2016, efforts to combat AMR have been made by the Government of Japan as well as through joint action from industry, government academia, and civil society. In addition to measures taken within its borders, Japan must continue leading global efforts against AMR in its capacity as a G7 member. Looking ahead to the 2024 UNGA High-level Meeting on AMR, we offer the following four recommendations for consideration during the formulation of the National Action Plan on AMR (2023-2027) (“the next NAP”).
Recommendation 1: Revision of package inserts should be proactively considered taking into account the actual situation at health care facilities (Related to Goal 2)
Recommendation 2: The Government should take the lead in creating and standardizing English names used within the medical service fee system and for related items and by establishing master databases for data related to healthcare and pharmaceuticals (Related to Goals 2, 3, and 6)
Recommendation 3: Steps should be taken to develop human resources and establish an environment to facilitate proactive AMR screening, microorganism identification, and drug susceptibility testing (including genetic testing through nucleic acid amplification tests) (Related to Goals 1, 2, and 5)
Recommendation 4: When providing final evaluations, the National Action Plan should include both outcome and process indicators that can used in a manner that allows for comparisons by regional characteristics (Related to National Action Plan performance indicators)
Top Research & Recommendations Posts
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Policy Recommendations] Strengthening Lifelong Mental Health Support for Children with Intellectual Disabilities (April 30, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
- [Event Report] Round Table Discussion “Understanding Menopausal Women’s Health as a Social Issue” (Preliminary Version) (November 19, 2024)
Featured Posts
-
2025-04-17
[Registration Open] (Webinar) The 134th HGPI Seminar “Understanding Evidence-Based Dietary Guidelines: Leveraging the Dietary Reference Intakes for Japanese” (May 28, 2025)
-
2025-04-23
[Registration Open] Recruitment of the Health Policy Academy the 14th Session (Starts July 2025)
-
2025-05-02
[Registration Open] (Webinar) The 133rd HGPI Seminar -HGPI Expert Policy Advocacy Platform- “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 20, 2025)
-
2025-05-07
[Recommendations] HGPI Expert Policy Advocacy Platform “Better Use of Cost-effectiveness Evaluation for Pharmaceuticals in Japan” (May 7, 2025)
-
2025-05-07
[Registration Open] Japan-Australia Online Round Table Discussion “The Impact of Social Media on the Mental Health of Children and Young People and How Social Media Should Be Used in Society“ (May 23, 2025)